AMGEN INC (AMGN) Options Risk Score

Run a full AMGN options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on AMGEN INC (AMGN) right now?

AMGEN INC (AMGN) currently scores 36 out of 100 for options catalyst risk (LOW) over a 4-week expiry window. That score is driven by an upcoming earnings report, 4 recent news items, 10 active legal filings and 13 clinical-trial catalysts falling inside the 4-week window. A LOW score (under 45) means the scan found no dated catalyst for AMGN inside the window. Read it as a clean calendar rather than a safe stock — surprises are by definition unscheduled.

AMGN shows an IV Rank of 83 — implied volatility is near the top of its own one-year range, so AMGN options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 40%. IV Rank is the most useful figure for deciding whether to sell or buy premium on AMGN.

AMGN reports on 2026-11-03. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

AMGEN INC (AMGN) current implied volatility and IV Rank

As of the latest scan, AMGEN INC (AMGN) shows an IV Rank of 83 with implied volatility around 40%, alongside a TickerRisk options-risk score of 36/100. That's high — options are expensive relative to the past year, which favours premium-selling strategies such as credit spreads, iron condors and covered calls, provided no binary catalyst is working against you.

For what this number does and does not tell you about AMGN's options, see IV Rank explained.

AMGEN INC (AMGN) next earnings date — 2026-11-03

AMGEN INC (AMGN) is scheduled to report on 2026-11-03 — about 58 days away, so a standard expiry would carry straight through it. AMGN's IV Rank is currently 83. Implied volatility tends to build into the date and drop sharply once results are public. If the premium on AMGN looks unusually generous right now, this is the most likely reason.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer